Phase II Trial of Alpelisib With iNOS Inhibitor and Nab-paclitaxel in Patients With HER2 Negative Metastatic or Locally Advanced Metaplastic Breast Cancer (MpBC)
NCT05660083 · RECRUITING · Phase 2
ReadTheTrial indexes 1 studies for Her2 Negative Breast Cancer. The most common development stage is Phase 2 (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.
1 clinical trials found for Her2 Negative Breast Cancer.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 2 | 1 | 100% |
There are 1 clinical trials listed for Her2 Negative Breast Cancer. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.
Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.
Current Her2 Negative Breast Cancer trials are distributed across: Phase 2 (1).